tazobactam has been researched along with Osteomyelitis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berenson, CS; Kurtzhalts, KE; Manohar, A; Mergenhagen, KA | 1 |
| Ourique, C; Rego-Costa, F; Torres-Ramalho, P | 1 |
| Borgia, G; Buonomo, AR; De Zottis, F; Di Renzo, G; Gentile, I; Maraolo, AE; Scotto, R | 1 |
| Arcenillas, P; Boix-Palop, L; Calbo, E; Cuchi, E; Dietl, B; Gómez, L; González de Molina, FJ; Nicolás, J; Sánchez, I | 1 |
| Cheng, V; Dyer, J; Ingram, P; McWhinney, BC; Raby, E; Rawlins, M; Regli, A; Roberts, JA; Ungerer, JPJ | 1 |
| Bernhardt, M; Boschert, EN; Dubin, JR; Lauer, MF | 1 |
| Duplessis, CA; McGann, P; Perkins, MJ; Snesrud, E | 1 |
| Berman, D; Bode, RS; Brachlow, AE; Capouya, JD; Enrione, MA; Forrster, EE; Fuh, BR; Pourrat, M | 1 |
| Behbahani, R; Kostman, JR | 1 |
9 other study(ies) available for tazobactam and Osteomyelitis
| Article | Year |
|---|---|
Successful treatment of multidrug-resistant
Topics: Cephalosporins; Cystectomy; Debridement; Drug Resistance, Multiple, Bacterial; Fistula; Humans; Male; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas Infections; Pubic Symphysis; Tazobactam; Treatment Outcome | 2017 |
Unusual course of a haematoma of the thigh.
Topics: Anti-Bacterial Agents; Delayed Diagnosis; Drainage; Female; Hematoma; Humans; Linezolid; Magnetic Resonance Imaging; Middle Aged; Muscle, Skeletal; Osteomyelitis; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Thigh | 2017 |
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fractures, Bone; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome | 2017 |
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome | 2018 |
Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy.
Topics: Anti-Bacterial Agents; Cephalosporins; Female; Half-Life; Humans; Kidney Failure, Chronic; Middle Aged; Osteomyelitis; Pseudomonas aeruginosa; Renal Replacement Therapy; Tazobactam | 2018 |
Intramedullary Antibiotic Delivery for Emphysematous Osteomyelitis of the Femur.
Topics: Anti-Bacterial Agents; Bone Cements; Bone Nails; Emphysema; Escherichia coli; Escherichia coli Infections; Female; Femur; Humans; Middle Aged; Osteomyelitis; Piperacillin; Tazobactam | 2019 |
Clostridium sphenoides Chronic Osteomyelitis Diagnosed Via Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry, Conflicting With 16S rRNA Sequencing but Confirmed by Whole Genome Sequencing.
Topics: Anti-Bacterial Agents; Chronic Disease; Clostridium; Clostridium Infections; Daptomycin; Fractures, Open; Humans; Male; Osteomyelitis; Penicillanic Acid; Piperacillin; Radius Fractures; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tazobactam; Ulna Fractures; Whole Genome Sequencing; Young Adult | 2017 |
Index of suspicion.
Topics: Acidosis; Adolescent; Appendectomy; Appendicitis; beta-Lactamase Inhibitors; Child; Comorbidity; Diagnosis, Differential; Ethylene Glycol; Female; Humans; Infant; Leukopenia; Male; Metabolism, Inborn Errors; Neutropenia; Osteomyelitis; Pelvic Inflammatory Disease; Penicillanic Acid; Poisoning; Tazobactam | 2005 |
Hypersensitivity reaction during prolonged use of piperacillin/tazobactam in treatment of osteomyelitis.
Topics: beta-Lactamase Inhibitors; Drug Hypersensitivity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Middle Aged; Osteomyelitis; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1995 |